First-line therapy in atypical hemolytic uremic syndrome: consideration on infants with a poor prognosis

BACKGROUND: Atypical hemolytic uremic syndrome (aHUS) is a rare and heterogeneous disorder. The first line treatment of aHUS is plasma therapy, but in the past few years, the recommendations have changed greatly with the advent of eculizumab, a humanized monoclonal anti C5-antibody. Although recent...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ital J Pediatr
Main Authors: Szarvas, Nóra, Szilágyi, Ágnes, Tasic, Velibor, Nushi-Stavileci, Valbona, Sofijanova, Aspazija, Gucev, Zoran, Szabó, Miklós, Szabó, Attila, Szeifert, Lilla, Reusz, György, Rusai, Krisztina, Arbeiter, Klaus, Müller, Thomas, Prohászka, Zoltán
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2014
Fag:
Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4295478/
https://ncbi.nlm.nih.gov/pubmed/25496981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13052-014-0101-7
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker